Amgen Jun 12, 2026 FDA hearing on Amgen's Tavneos will include findings from an independent review - Fierce Pharma
Amgen Jun 10, 2026 Ethyreal Bio manifests with $101M in pack of biotechs gunning for Amgen’s Tepezza - Fierce Biotech
Amgen Jun 1, 2026 EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER - Amgen
Amgen May 20, 2026 Amgen CFO Transition as Peter Griffith Retires, Thomas Dittrich Returns - Contract Pharma
Amgen May 20, 2026 Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus - Fierce Pharma
Amgen May 19, 2026 Amgen Inc. stock (US0311621009): weight-loss data and earnings keep biotech in focus - AD HOC NEWS
Amgen May 19, 2026 Biopharma bites: IRA is here to stay, plus more safety concerns for Amgen's Tavneos - FirstWord Pharma
Amgen May 18, 2026 Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug - BioPharma Dive
Amgen May 18, 2026 Amgen Inc. stock (US0311621009): earnings beat, dividend and guidance keep biotech giant in focus - AD HOC NEWS